Other
Hydrocortisone
0
Pipeline Programs↗
3
Active Trials↗
1
Companies Involved↗
Hydrocortisone is an early-stage landscape with 0 programs across 1 company. The most active players are US Oncology Research.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
27
clinical trials
Completed20 · 74%
Recruiting2 · 7%
Terminated2 · 7%
Not yet recruiting1 · 4%
Unknown status1 · 4%
Withdrawn1 · 4%
Clinical Trials
Trial Activity
27 trials
Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics
Not yet recruiting·HHospital Universitari Vall d'Hebron Research Institute·Phase 4·NCT06435481·35 enrolled
A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension
Completed·—·Phase 3·NCT00980876·224 enrolled
PTSD Prevention Using Oral Hydrocortisone
Completed·—·Phase 2·NCT04924166·201 enrolled
Administration of Hydrocortisone in Young Healthy Male Volunteers
Completed·—·Phase 4·NCT04137302·21 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)